Sinotherapeutics Inc. A (688247) — Net Asset Momentum

Latest YoY growth as of December 2025: +1.5%

Sinotherapeutics Inc. A (688247) recorded a net asset momentum of 1.5% as of December 2025, with net assets of CN¥1.29 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check Sinotherapeutics Inc. A tangible book value ratio to evaluate the tangible quality of the company's equity base.

YoY Momentum

+1.5%
Year-over-year

Current Net Assets

CN¥1.29 Billion
CNY · December 2025

Years of Data

6
2020 – 2025

Country

China
SHG

Sinotherapeutics Inc. A Net Asset Momentum (2020–2025)

This chart tracks Sinotherapeutics Inc. A's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is +1.5%, with net assets of CN¥1.29 Billion CNY as of December 2025. Read total liabilities of Sinotherapeutics Inc. A for a breakdown of total debt and financial obligations.

Annual Net Asset History for Sinotherapeutics Inc. A (2020–2025)

The table below shows the complete annual net asset history for Sinotherapeutics Inc. A from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Sinotherapeutics Inc. A (688247) market capitalisation.

Year Net Assets (CNY) Total Assets Total Liabilities YoY Momentum
2025 CN¥1.29 Billion CN¥1.44 Billion CN¥146.12 Million ▲ +1.5%
2024 CN¥1.27 Billion CN¥1.45 Billion CN¥180.30 Million ▲ +5.2%
2023 CN¥1.21 Billion CN¥1.36 Billion CN¥151.36 Million ▲ +2.8%
2022 CN¥1.18 Billion CN¥1.33 Billion CN¥155.05 Million ▲ +66.9%
2021 CN¥705.19 Million CN¥865.81 Million CN¥160.62 Million ▲ +25.4%
2020 CN¥562.38 Million CN¥743.14 Million CN¥180.76 Million